In a contentious development, major automakers, including General Motors, Toyota Motor, and Volkswagen, alongside airbag manufacturers ARC Automotive and Delphi Automotive, have voiced their opposition to the U.S. National Highway Traffic Safety Administration’s (NHTSA) proposal to recall 52 million airbag inflators. The move comes after NHTSA officials argued that inflators from the two manufacturers could rupture, posing safety risks.
Safety concerns and recall proposal
NHTSA officials presented their case in October, asserting that inflators produced by ARC Automotive and Delphi Automotive were prone to rupture, potentially releasing metal fragments. The safety concern, linked to one fatality and seven injuries, prompted NHTSA’s call for a recall, marking a significant step in addressing safety issues associated with airbag inflators.
Automaker and manufacturer opposition
Major automakers, including GM, Toyota, and Volkswagen, as well as airbag manufacturers ARC and Delphi, contested the recall proposal. They argued that the risks associated with the inflators were minimal and questioned the basis for the recall. ARC emphasised that, according to NHTSA’s estimated failure rate, there would be less than one new rupture over the next 33 years.
Scope and impact on automakers
The inflators in question were used in vehicles produced from 2000 through early 2018 by 12 automakers, including Ford, Mercedes-Benz, BMW, Hyundai, Kia, and Porsche. GM, which had recalled 1 million ARC inflators in May, expressed concern over the proposed “massive and unprecedented expansion” of the recalls, potentially affecting up to 15% of registered motor vehicles in the U.S.
Challenges to NHTSA’s decision
Both GM and Stellantis challenged NHTSA’s decision, labelling it “arbitrary, capricious, and contrary to law.” Reuters reported potential impacts on over 20 million GM vehicles, while Stellantis highlighted the limited instances of ruptures, asserting the lack of compelling evidence to justify a recall.
Manufacturer stance and licensing agreement
Delphi Automotive, operating under Autoliv, contested the recall, indicating that NHTSA had not proven the inflators to be defective. Autoliv, opposing the recall, underscored the absence of evidence supporting the claim of a systemic defect. Notably, Delphi manufactured around 11 million inflators through 2004 under a licensing agreement with ARC, which produced the remaining 41 million.
Regulator’s perspective and safety implications
NHTSA’s enforcement official, Cem Hatipoglu, defended the recall bid, acknowledging that while the odds of a rupture might be low, the potential consequences were severe and potentially deadly. The regulator’s insistence on the recall stems from its commitment to ensuring the safety and well-being of vehicle occupants.
Complexities and ongoing debate
The opposition from automakers and manufacturers adds complexity to the ongoing debate about the necessity and scope of the proposed recall. As safety concerns persist, the industry grapples with striking a balance between addressing potential risks and challenging regulatory decisions perceived as unwarranted.
The controversy surrounding the proposed recall of 52 million airbag inflators reveals a nuanced debate between regulators, automakers, and manufacturers. As safety remains paramount, the industry navigates the intricate landscape of addressing potential defects while scrutinizing the basis for regulatory decisions.